Adiponectin Is Associated with Brain Natriuretic Peptide and Left Ventricular Hypertrophy in Hemodialysis Patients with Type 2 Diabetes Mellitus
- 21 September 2007
- journal article
- clinical trial
- Published by S. Karger AG in Nephron Clinical Practice
- Vol. 107 (3) , c103-c108
Abstract
Background: Adiponectin, an adipocyte-derived hormone, has been shown to prevent the progression of left ventricular hypertrophy (LVH). However, recent studies have demonstrated increased levels of adiponectin according to the severity of chronic heart failure. We therefore investigated the relationships between adiponectin, brain natriuretic peptide (BNP), and LVH in type 2 diabetic patients on hemodialysis. Methods: The study population comprised 41 type 2 diabetic patients on hemodialysis. Left ventricular mass index (LVMI) and criteria for LVH were determined on the basis of echocardiographic findings. Serum adiponectin and plasma BNP levels were assayed with a commercially available kit. Results: Serum adiponectin levels significantly correlated with BMI (r = –0.49, p < 0.01), HDL-C (r = 0.36, p < 0.05) and TG (r = –0.49, p < 0.01). In addition, serum adiponectin levels correlated significantly and positively with plasma BNP levels (r = 0.36, p < 0.05). This relationship remained significant after adjustment for age, gender, and BMI (r = 0.34, p < 0.05). Serum adiponectin levels as well as plasma BNP levels were significantly higher than in patients without LVH (p < 0.05; p < 0.01, respectively), accompanied by a positive correlation between these levels and LVMI (r = 0.42, p < 0.01; r = 0.32, p < 0.05, respectively). Conclusion: Increased levels of adiponectin were associated with elevated BNP levels and LVH in hemodialysis patients with type 2 diabetes mellitus. It is speculated that adiponectin levels may be modulated by chronic hypervolemic state in this population.Keywords
This publication has 26 references indexed in Scilit:
- Increased Serum High-Molecular-Weight Complex of Adiponectin in Type 2 Diabetic Patients with Impaired Renal FunctionAmerican Journal of Nephrology, 2006
- Adiponectin and Mortality in Patients with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2006
- Relationship of Adiponectin with Markers of Systemic Inflammation, Atherogenic Dyslipidemia, and Heart Failure in Patients with Coronary Heart DiseaseClinical Chemistry, 2006
- Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart FailureCirculation, 2005
- Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney DiseaseJournal of the American Society of Nephrology, 2005
- Blockade of the Renin-Angiotensin System Increases Plasma Adiponectin Levels in Type-2 Diabetic Patients with ProteinuriaNephron Clinical Practice, 2005
- Association between C-Reactive Protein Levels and N-Terminal Pro-B-Type Natriuretic Peptide in Pre-Dialysis PatientsNephron Clinical Practice, 2004
- Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose TissueCirculation, 2003
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977